Maternal drug use and its effect on neonates: A population-based study in Washington State

Obstetrics and Gynecology

Volumn 119, Issue 5, 2012, Pages 924-933

  Creanga, Andreea A ^a,b   Sabel, Jennifer C ^a,b   Ko, Jean Y ^a,b   Wasserman, Cathy R ^a,b   Shapiro Mendoza, Carrie K ^a,b   Taylor, Polly ^a,b   Barfield, Wanda ^a,b   Cawthon, Laurie ^a,b   Paulozzi, Leonard J ^a,b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Research and Data Analysis Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DRUG DEPENDENCE; FEEDING DISORDER; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN DISEASE; PREGNANCY OUTCOME; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; UNITED STATES; WITHDRAWAL SYNDROME;

ADULT; ANALGESICS, OPIOID; COCAINE; FEMALE; HUMANS; INFANT, NEWBORN; LINEAR MODELS; LOGISTIC MODELS; MALE; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; WASHINGTON;

EID: 84860132028     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31824ea276     Document Type: Article

References (35)

1. Havens JR, Simmons LA, Shannon LM, Hansen WF. Factors associated with substance use during pregnancy: results from a national sample. Drug Alcohol Depend 2009;99:89-95.
2. Greenfield SF, Manwani SG, Nargiso JE. Epidemiology of substance use disorders in women. Obstet Gynecol Clin North Am 2003;30:413-46. (Pubitemid 37420305)
3. Azuma SD, Chasnoff IJ. Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of threeyear data. Pediatrics 1993;92:396-402. (Pubitemid 23264636)
4. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings. 2010. Available at: www.oas.samhsa.gov/2k8State/Ch2.htm#2.7. Retrieved January 31, 2012.
5. Kellogg A, Rose CH, Harms RH, Watson WJ. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol 2011;204:259.e1-4.
6. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010;363:1981-5.
7. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010;13:401-35.
8. Washington State Department of Social and Health Services 2010 Report. Tobacco, alcohol, & other drug abuse trends in Washington State. 2010. Available at: www.dshs.wa.gov/dbhr. Retrieved January 31, 2012.
9. Washington State Department of Health. The Health of Washington State. Appendix B: primary data sources. 2007. Available at: www.doh.wa.gov/HWS/doc/ AppendixB2007.pdf. Retrieved January 31, 2012.
10. Healthcare Cost and Utilization Project Databases. Rockville (MD): Agency for Healthcare Research and Quality; 2010. Available at: www.hcup-us.ahrq.gov/ nisoverview.jsp. Retrieved January 31, 2012.
11. Kuklina EV, Whiteman MK, Hillis SD, Jamieson DJ, Meikle SF, Posner SF, et al. An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J 2008;12:469-77.
12. Cuzick J. Wilcoxon-type test for trend. Stat Med 1985;4:87-90.
13. O'Donnell M, Nassar N, Leonard H, Hagan R, Mathews R, Patterson Y, et al. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement. Pediatrics 2009;123:e614-21.
14. Drug Enforcement Administration. Automation of Reports and Consolidated Orders System. Retail drug summary. Available at: www.deadiversion.usdoj.gov/ arcos/retail-drug-summary/index.html. Retrieved January 31, 2012.
15. Jansson LM, Dipietro JA, Elko A, Velez M. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates. J Matern Fetal Neonatal Med 2007;20:677-85. (Pubitemid 47262703)
16. Muhuri PK, Gfroerer JC. Substance use among women: associations with pregnancy, parenting, and race/ethnicity. Matern Child Health J 2009;13:376-85.
17. Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003; 101:374-9. (Pubitemid 36170140)
18. Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug Alcohol Rev 2007;26:487-92.
19. Bucholz KK. Nosology and epidemiology of addictive disorders and their comorbidity. Psychiatr Clin North Am 1999;22: 221-40. (Pubitemid 29275795)
20. Wachman EM, Byun J, Philipp BL. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med 2010;5:159-64.
21. Preen DB, Holman CD, Lawrence DM, Baynham NJ, Semmens JB. Hospital chart review provided more accurate comorbidity information than data from a general practitioner survey or an administrative database. J Clin Epidemiol 2004; 57:1295-304. (Pubitemid 40023150)
22. Cleary BJ, Donnelly JM, Strawbridge JD, Gallagher PJ, Fahey T, White MJ, et al. Methadone and perinatal outcomes: a retrospective cohort study. Am J Obstet Gynecol 2011;204: 139.e1-9.
23. Lydon-Rochelle MT, Holt VL, Nelson JC, Cárdenas V, Gardella C, Easterling TR, et al. Accuracy of reporting maternal in-hospital diagnoses and intrapartum procedures in Washington State linked birth records. Paediatr Perinat Epidemiol 2005;19:460-71. (Pubitemid 41693363)
24. Lester BM, ElSohly M, Wright LL, Smeriglio VL, Verter J, Bauer CR, et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 2001;107:309-17. (Pubitemid 32121247)
25. At risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. ACOG Committee Opinion No. 422. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008;112:1449-60.
26. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy for chronic noncancer pain. J Pain 2009;10: 113-30.
27. Little BB, Snell LM, Van Beveren TT, Crowell RB, Trayler S, Johnston WL. Treatment of substance abuse during pregnancy and infant outcome. Am J Perinatol 2003;20:255-62. (Pubitemid 37070595)
28. Cox S, Posner SF, Kourtis AP, Jamieson DJ. Hospitalizations with amphetamine abuse among pregnant women. Obstet Gynecol 2008;111:341-7. (Pubitemid 351653424)
29. Dryden C, Young D, Hepburn M, Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009;116:665-71.
30. Seligman NS, Salva N, Hayes EJ, Dysart KC, Pequignot EC, Baxter JK. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol 2008;199:396.e1-7.
31. Farmer Y, Cawthon L, Salazar E. Comprehensive program evaluation project report. 2000. Available at: www.dshs.wa. gov/pdf/ms/rda/research/4/36/a.pdf. Retrieved January 31, 2012.
32. Estee S, Norlund D. Washington State Supplemental Security Income (SSI) Cost Offset Pilot Project: 2002 progress report. 2003. Available at: www.dshs.wa.gov/pdf/ms/rda/research/11/109.pdf. Retrieved January 31, 2012.
33. Armstrong EM. Drug and alcohol use during pregnancy: we need to protect, not punish, women. Womens Health Issues 2005;15:45-7. (Pubitemid 40357927)
34. Substance abuse reporting in pregnancy: the role of the obstetrician-gynecologist. ACOG Committee Opinion No. 473. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;117:200-1.
35. Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J Perinatol 2008;28:597-603.